The 2025 Taiwan Healthcare+ Expo concluded on December 7 in Taipei, centered on the theme of "Scaling Global Connectivity." The event highlighted Taiwan's emergence as a strategically valuable hub for medical landing, evidenced by a €200 million Czech procurement deal, the first visit by a collective of heavyweight global VCs, and a historic partnership between Taiwan’s SNQ (Symbol of National Quality) and ICHOM.

Wong Chi-huey, Chairman of IBMI (Institute for Biotechnology and Medicine Industry), noted that while Taiwan possesses a strong medical and R&D foundation, early synchronization with international capital and technology is essential for local innovations to penetrate global markets.

Key Highlights:

• Czech Procurement: The Czech Health Technology Institute (CHTI) signed an MOU with IBMI to launch a €200 million (approx. NT$7.4 billion) procurement plan. This covers 20 categories of Taiwanese medical devices, including ICU ventilators, life-monitoring equipment, and fetal ECG monitors, aimed at strengthening maternal health and hospital resilience in Sub-Saharan Africa.
• The "Taiwan Team": The initial procurement list includes 10 major players: Heroic, Varian (partnering with local firms), BenQ/Qisda, Syncell, Quanta, ASUS, Darfon (AUO Group), Foxconn (partnering with NVIDIA and Kawasaki Heavy Industries), China Medical University (with Everest Medicines), and Wistron.
• SNQ & ICHOM Partnership: For the first time in Asia, Taiwan’s 28-year-old SNQ label became a strategic partner of the International Consortium for Health Outcomes Measurement (ICHOM). SNQ will adopt ICHOM’s Patient-Reported Outcome Measures (PROMs) standards to enhance clinical process improvement and the credibility of Taiwan’s cross-border healthcare services.

Resource: 台灣醫療科技展 接軌國際